Shree Ganesh Remedies Ltd (BSE: 540737) is a Ankleshwar, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹882 Cr, it ranks #1,666 by market cap among the 6,137 Indian listed companies on FinBizNet, and #50 of 86 in Medicinal Chemicals and Botanical Products. At ₹693.90 (as of 25 Oct 2026), the share price is 7.5% below its 52-week high of ₹749.85 and 41.6% above its 52-week low of ₹490.00. The share price is up 40.1% over one year and up 4.2% over three months.
| Current Price | ₹693.90 |
|---|---|
| Market Cap | ₹882 Cr |
| BSE Code | 540737 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 50.2 |
| Return on Equity | 11.53% |
| Return on Assets | 8.08% |
| 52-Week Range | ₹490.00 – ₹749.85 |
| 1-Year Price Change | +40.1% |
| 3-Month Price Change | +4.2% |
| Beta (1Y) | 0.38 |
| Dividend Yield | 0.00% |
| Headquarters | Ankleshwar, Gujarat |
| Website | www.ganeshremedies.com |
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India and internationally. The company offers anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, antifungal, antihistamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. It also provides fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals. In addition, the company offers customized chemistry development and manufacturing; assets and infrastructure; and customized processes of pharmaceutical chemicals. It also exports its products. The company serves life sciences, flavor and fragrance, polymer industries, electronics, and agro chemicals ma
1. Bulk Drug Intermediates-This segment engages in the pharmaceutical intermediates and specialty chemical businesses.
1. Bulk Drug Intermediates-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Shree Ganesh Remedies Ltd | ₹882 Cr | 50.2 | 11.53% | — | +40.1% |
Listed by market capitalisation. Ratios are shown for context only.
Shree Ganesh Remedies Ltd is trading at ₹693.90, with a market capitalisation of ₹882 Cr.
Shree Ganesh Remedies Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Shree Ganesh Remedies Ltd has a P/E of 50.2 and a return on equity of 11.53%.
Shree Ganesh Remedies Ltd is listed on the BSE under the scrip code 540737.
Shree Ganesh Remedies Ltd's share price is up 40.1% over one year and up 4.2% over three months. Its 52-week range is ₹490.00 to ₹749.85.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.